Project NEIMO

NEuroInflammation MOnitoring

NEIMO is a translational research project implemented by Paris Brain Institute and Yale University (United States) that seeks to detect the early signs of neuroinflammation in individuals at risk of developing neurodegenerative diseases, such as Parkinson’s disease and multiple sclerosis. Early detection will enable proactive management before the onset of major nerve damage and behavioral changes in individuals developing these disorders.

Cutting-edge approaches for imaging and detecting neuroinflammation

The teams at Yale and Paris Brain Institute combine expertise and cutting-edge technologies in brain imaging and neuroimmunology. Their proven and complementary collaboration aims to push the boundaries of research on neuroinflammation.

PROJECT OBJECTIVES

1. Detect early signs of neuroinflammation through blood tests and advanced imaging.
2. Observe cerebral fluid drainage and inflammation using MRI to identify early markers.
3. Develop artificial intelligence tools to analyze data automatically.
4. Create predictive models of progression and treatments.
5. Share tools and data with the scientific community.

MAJOR ADVANCES

The project is progressing thanks to an agreement signed between Paris Brain Institute and Yale. Personnel recruitment has been completed and regular meetings ensure the smooth coordination of the project. Advances in brain imaging and computational tools support this innovative project, bringing together experts in neuroimmunology and imaging to better control neuroinflammation in neurodegenerative diseases.